Table 3.

Pharmacodynamic parameters among healthy subjects (phase I study).

	Aspirin + placebo	Aspirin + BJIKT	P
TxB2 (pg/ml)
0 min	173.6 ± 41.2	163.4 ± 41.8	NS
5 min	68.5 ± 14.8	61.7 ± 21.5	NS
10 min	55.81 ± 10.9	47.6 ± 13.9	NS
20 min	58.8 ± 17.8	47.6 ± 16.8	NS
30 min	70.1 ± 36.7	59.9 ± 17.8	NS
45 min	70.9 ± 25.2	71.9 ± 15.7	NS
60 min	78.9 ± 18.7	75.4 ± 21.1	NS
PLT agg (%)
0	77.4 ± 5.4	78.1 ± 5.4	NS
2 hours	76.1 ± 8.6	78.9 ± 5.5	NS
4 hours	66.7 ± 14.7	66.9 ± 14.9	NS

BJIKT: Bojungikki-tang, TxB₂: thromboxane B₂, PLT agg: platelet aggregation.